Daniel Wagner, Connecticut Innovations

Judge, Northeast (Yale) Regional Finals
LinkedIn

Dan is responsible for evaluating investment opportunities, structuring new investments and monitoring portfolio companies at CI. Dan contributes to CI’s expertise in biotech with more than 10 years in the industry. He was previously employed by successful former CI biopharmaceutical portfolio company; CuraGen Corporation. At CuraGen, Dan held a variety of scientific and operational management positions in R&D and technology assessment helping advance CuraGen’s protein, antibody and small-molecule therapeutics.

Current companies;
•Arvinas (Board Observer)
•CMD Bioscience (Board Member)
•EpiEP, Inc. (Board Observer)
•FMP Products (Board Member)
•Innovatient Solutions (Board Member)
•New Haven Pharmaceuticals (Board Member)
•P2 Science (Board Member)
•Sami Health (Board Member)
•Soft Tissue Regeneration (Board Member)

Education
•B.S., Biology, University of Dayton
•M.H.S., Biomedical Sciences, Quinnipiac University
•M.B.A., Finance, Quinnipiac University